EDI

Advancing Research That Saves Lives

Discover how BioCanRx supports scientists driving the next generation of cancer immunotherapies.

Explore Research Funding Programs

From proof of concept to patient delivery, BioCanRx supports every step.

BioCanRx funds cancer immunotherapy research, including cell therapies, therapeutic vaccines, antibodies, immune modulators, and combination treatments. We also support enabling technologies and work to address barriers to clinical adoption.
science-research-woman-with-sample-glass-medical-development-virus-inspection-ppe-biotech-test-scientist-mask-vaccine-innovation-health-study-bacteria-growth-lab

Catalyst Program

Advance proof-of-concept innovations
discussing-financial-reports

Enabling Studies Program

Work to enable CMC and CTA regulatory packages
doctor-is-asking-patient-symptom

Clinical Trial Program

Launch and support early phase clinical trials
Laboratory glassware placed over a bar chart representing cancer clinical trials in Canada and translational research funding outcomes supported by BioCanRx.

Clinical, Social and Economic Impact Program

Address barriers to ultimate health system adoption

Funding Opportunities

Apply for Research Funding

BioCanRx offers five funding streams supporting cancer immunotherapy research from proof-of-concept to early-phase clinical trials. Programs are designed to accelerate innovation and build national research capacity.

Application Process Overview

Understand the steps and criteria for submitting a successful funding application.

Learn more

Program Descriptions

Get detailed into on our five funding streams and what each supports.

Learn more

Funded Research

Browse current and past projects we've supported across Canada.

Learn more

Funded Programs

Advancing Research Through Targeted Funding

BioCanRx funds innovations across the translational pipeline and supports research into social, legal, and health-system barriers. We also fund core facilities offering specialized services like biotherapeutics manufacturing and commercialization expertise.

Our pipeline funding model helps researchers advance promising innovations to the next stage of translation more cost-effectively and more efficiently.

Catalyst Program

Enabling Studies Program

Clinical Trials Program

Clinical, Social and Economic Impact Program

Core Facilities Program

Core Facilities

Access the Services Driving Discovery

The Core Facilities Program supports one part of a complex innovation journey – ensuring researchers have timely and cost-effective access to the resources they need to move their projects forward. BioCanRx has forged partnerships that empower researchers to go beyond their institutional boundaries to access expert advice and manufacturing capacity to navigate the “valley of death” in translational research.
Two scientists walking through a biomanufacturing facility equipped for large-scale cell therapy production and cancer immunotherapy development in Canada.

Researcher Profiles

Meet the Scientists Behind the Science

Explore our network of investigators and collaborators leading groundbreaking research across Canada. Learn about their expertise, current projects, and contributions to advancing cancer immunotherapies.

Group of researchers and leaders meeting to discuss strategic initiatives at BioCanRx, Canada’s leading cancer immunotherapy and translational research institute.